Scientists at Neoleukin Therapeutics applied their protein design technology to the new coronavirus and created an antiviral molecule in record time.
How One Company Pivoted From Cancer To Coronavirus And Designed A Virus-Blocking Drug In 10 Weeks
Scientists at Neoleukin Therapeutics applied their protein design technology to the new coronavirus and created an antiviral molecule in record time.